RACHEL SERRANO: Open Payments
NPI 1043613839 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,760 in 177 payments from 19 companies in 2025. Trend: 2023 $293 · 2024 $3,365 · 2025 $6,760
Food & beverage: $5,461Consulting: $1,000Education: $299
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $1,527 |
| ABBVIE INC. | 22 | $726 |
| Janssen Biotech, Inc. | 24 | $649 |
| UCB, Inc. | 14 | $433 |
| Galderma Laboratories, L.P. | 16 | $432 |
| Novartis Pharmaceuticals Corporation | 6 | $364 |
| GENZYME CORPORATION | 4 | $351 |
| E.R. Squibb & Sons, L.L.C. | 12 | $342 |
| Arcutis Biotherapeutics, Inc. | 17 | $331 |
| Amgen Inc. | 6 | $320 |
Products named: Winlevi, TREMFYA, DUPIXENT, RINVOQ, Bimzelx, Sotyktu, Zoryve, NEMLUVIO.
Industry payments across NC — which companies pay providers there.
